news
Neutralising monoclonal antibodies protected aged macaque monkeys from SARS-CoV-2 and…
2 November 2021 | By Anna Begley (Drug Target Review)
Neutralising monoclonal antibodies protected aged macaque monkeys from SARS-CoV-2 and reduced inflammation, including in cerebrospinal fluid, a new study has shown.